BAC
Bank of America Corporation
BAC has the edge over UVSP overall, supported by stronger valuation and stronger fundamentals.
UVSP
Univest Financial Corporation
UVSP's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
UVSP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
UVSP's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like UVSP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over UVSP in the historical PE scenario, which offers more potential upside but is not a forecast.
UVSP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $27.35 | -33% |
| Forward | 10x | $40.74 | — |
| Fair | 11x | $35.68 | -12% |
| Expensive | 12x | $40.81 | +0.2% |
| Current | 12x | $40.74 | — |
Historical ranges are pointers, not guarantees.
UVSP's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
UVSP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UVSP, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over UVSP on earnings, with stronger typical year-over-year growth.
UVSP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.90 | +17% |
| Q3 2026 | $3.34 | +12% |
| Q2 2026 | $3.45 | +26% |
| Q1 2026 | $3.32 | +25% |
| Q4 2025 | $3.13 | +21% |
| Q3 2025 | $2.99 | +20% |
| Q2 2025 | $2.73 | +12% |
| Q1 2025 | $2.66 | +11% |
| Q4 2024 | $2.58 | +7.1% |
UVSP's earnings per share have climbed steadily: $3.34 over the past year, up 12% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over UVSP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
UVSP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $90M | +8.1% |
| Q2 2026 | $84.4M | +4.1% |
| Q1 2026 | $87.5M | +10% |
| Q4 2025 | $84.6M | +10% |
| Q3 2025 | $83.2M | +13% |
| Q2 2025 | $81M | +13% |
| Q1 2025 | $79.2M | +2.8% |
| Q4 2024 | $76.8M | +7.6% |
UVSP's revenue has grown year over year for nine quarters in a row: $90M last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -8.5 points |
| Q2 2026 | 34% | +3 points |
| Q1 2026 | 38% | +3.5 points |
| Q4 2025 | 34% | +3 points |
| Q3 2025 | 39% | +6.6 points |
| Q2 2025 | 31% | -0.5 points |
| Q1 2025 | 35% | +1.6 points |
| Q4 2024 | 31% | +2.4 points |
UVSP has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
UVSP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $45.2M | +44% |
| Q2 2026 | $22.9M | +4.5% |
| Q1 2026 | $21.6M | +58% |
| Q4 2025 | $30M | +9.5% |
| Q3 2025 | $31.4M | -18% |
| Q2 2025 | $21.9M | +$26.1M |
| Q1 2025 | $13.7M | +30% |
| Q4 2024 | $27.4M | +3.9% |
UVSP has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over UVSP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
UVSP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -215K shares |
| 1 year | -4.2% | -1.2M shares |
| 3 years | -6.1% | -1.8M shares |
| 5 years | -6.1% | -1.8M shares |
| Available history | -5.3% | -1.6M shares |
UVSP has 28M diluted shares, down 4.2% from a year ago, with $57M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $12.9M |
| Q2 2026 | $16.6M |
| Q1 2026 | $11.9M |
| Q4 2025 | $15.4M |
| Q3 2025 | $7.8M |
| Q2 2025 | $4.9M |
| Q1 2025 | $6.5M |
| Q4 2024 | $4.2M |
UVSP spent $57M buying back its own shares over the past year, up 143% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
UVSP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 3.1x | Elevated |
UVSP has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
UVSP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.9 | Neutral |
| Stochastic | 24.4 | Neutral |
UVSP's weekly RSI is 50 (neutral) and its Stochastic is 24 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over UVSP on valuation relative to its sector.
UVSP PE vs Financial Services Sector
| Metric | UVSP | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.3% below |
| PE % | 82 | 63 | 19 pts above |
UVSP is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UVSP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.1 | 0.9% below |
| 20 week MA | $42.3 | 3.7% below |
| 50 week MA | $38.6 | 5.6% above |
| 100 week MA | $34.2 | 19% above |
| 200 week MA | $28.3 | 44% above |
UVSP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
UVSP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.7 | $20.4 | -24% |
| 2021 | $20.4 | $29.7 | +46% |
| 2022 | $29.7 | $26.3 | -12% |
| 2023 | $26.3 | $22.0 | -16% |
| 2024 | $22.0 | $29.5 | +34% |
| 2025 | $29.5 | $33.4 | +13% |
| 2026 YTD | $33.4 | $40.7 | +22% |
UVSP has the edge over BAC on returns for 2026, with the stronger performance.